Federated Hermes, Inc. Chemo Centryx, Inc. Transaction History

Federated Hermes, Inc.

$43.6 Billion
Q3 2024

Shares

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2022 Aug 15, 2022	SELL	$15.36 - $27.51 $755,112 - $1.35 Million	-49,161 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$22.22 - $39.12 $1.09 Million - $1.92 Million	49,161 New	49,161 $1.23 Million
Q4 2021 Feb 14, 2022	SELL	$18.38 - $40.5 $9.99 Million - $22 Million	-543,502 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$13.18 - $19.83 $7.16 Million - $10.8 Million	543,502 New	543,502 $9.29 Million
Q1 2021 May 13, 2021	SELL	$49.53 - $68.4 $1.69 Million - $2.33 Million	-34,073 Closed	0 $0
Q4 2020 Feb 12, 2021	SELL	$47.25 - $65.16 $575,883 - $794,170	-12,188 Reduced 26.35%	34,073 $2.11 Million
Q3 2020 Nov 12, 2020	SELL	$46.35 - $61.69 $1.04 Million - $1.38 Million	-22,413 Reduced 32.64%	46,261 $2.54 Million
Q2 2020 Aug 13, 2020	BUY	$38.58 - $65.07 $1.19 Million - $2 Million	30,726 Added 80.97%	68,674 $3.95 Million
Q1 2020 May 13, 2020	BUY	$32.73 - $50.78 $697,541 - $1.08 Million	21,312 Added 128.11%	37,948 $1.53 Million
Q4 2019 Feb 14, 2020	SELL	$6.81 - $39.55 $52,995 - $307,778	-7,782 Reduced 31.87%	16,636 $658,000
Q3 2019 Nov 14, 2019	SELL	$6.47 - $8.96 $817,859 - $1.13 Million	-126,408 Reduced 83.81%	24,418 $165,000
Q2 2019 Aug 14, 2019	BUY	$8.31 - $14.85 $1.25 Million - $2.23 Million	150,286 Added 27830.74%	150,826 $1.4 Million
Q1 2019 May 10, 2019	SELL	$10.01 - $13.89 $652,862 - $905,919	-65,221 Reduced 99.18%	540 $8,000
Q3 2018 Nov 13, 2018	SELL	$10.49 - $13.72 $8,475 - $11,085	-808 Reduced 1.21%	65,761 $831,000
Q2 2018 Aug 10, 2018	BUY	$10.62 - $13.98 $135,500 - $178,370	12,759 Added 23.71%	66,569 $877,000
Q1 2018 May 09, 2018	SELL	$5.9 - $14.99 $63,720 - $161,892	-10,800 Reduced 16.72%	53,810 $732,000
Q3 2017 Nov 13, 2017	BUY	$6.5 - $10.69 $419,965 - $690,680	64,610	64,610 $479,000

Others Institutions Holding CCXI

# of Institutions

6

Shares Held

66.3K

Call Options Held

0

Put Options Held

0

About ChemoCentryx, Inc.

Ticker CCXI
Exchange NASDAQ
Shares Outstandng 71,919,696
Market Cap $3.68M
Description
ChemoCentryx, Inc., a biopharmaceutical company, focuses on the development and commercialization of new medications for inflammatory disorders, autoimmune diseases, and cancer in the United States. It offers TAVNEOS (avacopan), an orally administered selective C5aR inhibitor for the treatment of adult patients with severe active anti-neutrophil...

More about CCXI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Federated Hermes, Inc. with notifications on news.